Clinical Trials · NCT06894784
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Enrollment
- 36
- Start date
- Apr 2025
- Locations
- 1 site, Canada
- Primary endpoint
- Time-in-Range